The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
Open accessAbstract
In 2005, the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR) published a catalog of all of the human gene sequences known or predicted to encode G protein-coupled receptors (GPCRs), excluding sensory receptors. This review updates the list of orphan GPCRs and describes the criteria used by NC-IUPHAR to recommend the pairing of an orphan receptor with its cognate ligand(s). The following recommendations are made for new receptor names based on 11 pairings for class A GPCRs: hydroxycarboxylic acid receptors [HCA1 (GPR81) with lactate, HCA2 (GPR109A) with 3-hydroxybutyric acid, HCA3 (GPR109B) with 3-hydroxyoctanoic acid]; lysophosphatidic acid receptors [LPA4 (GPR23), LPA5 (GPR92), LPA6 (P2Y5)]; free fatty acid receptors [FFA4 (GPR120) with omega-3 fatty acids]; chemerin receptor (CMKLR1; ChemR23) with chemerin; CXCR7 (CMKOR1) with chemokines CXCL12 (SDF-1) and CXCL11 (ITAC); succinate receptor (SUCNR1) with succinate; and oxoglutarate receptor [OXGR1 with 2-oxoglutarate]. Pairings are highlighted for an additional 30 receptors in class A where further input is needed from the scientific community to validate these findings. Fifty-seven human class A receptors (excluding pseudogenes) are still considered orphans; information has been provided where there is a significant phenotype in genetically modified animals. In class B, six pairings have been reported by a single publication, with 28 (excluding pseudogenes) still classified as orphans. Seven orphan receptors remain in class C, with one pairing described by a single paper. The objective is to stimulate research into confirming pairings of orphan receptors where there is currently limited information and to identify cognate ligands for the remaining GPCRs. Further information can be found on the IUPHAR Database website (http://www.iuphar-db.org).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–230 of 230
Jones, P. M., Nawoschik, S. P., SREEKUMAR, K., Uveges, A. J., Tseng, E., ZHANG, L., Johnson, J. L., He, L., Paulsen, J. E., & Bates, B. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.01.013 · Cited by 67
GPR119 Agonists for the Potential Treatment of Type 2 Diabetes and Related Metabolic Disorders
Shah, U., & Kowalski, T. J. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00016-3 · Cited by 63
Chen, H., & Ikeda, S. R. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0990-04.2004 · Cited by 63
GPR56 and TG2: Possible Roles in Suppression of Tumor Growth by the Microenvironment
Xu, L., & Hynes, R. O. (2007) · Cell Cycle · doi:10.4161/cc.6.2.3760 · Cited by 62
Neuropeptide B and W: neurotransmitters in an emerging G‐protein‐coupled receptor system
Singh, G., & Davenport, A. P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706825 · Cited by 59
Self-citationInternational Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature
Maguire, J. J., Parker, W. A., Foord, S. M., Bonner, T. I., Neubig, R. R., & Davenport, A. P. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001107 · Cited by 59
Self-citationInduction of macroautophagy by overexpression of the Parkinson's disease‐associated GPR37 receptor
Marazziti, D., Pietro, C. D., Golini, E., Mandillo, S., Matteoni, R., & Tocchini‐Valentini, G. P. (2009) · The FASEB Journal · doi:10.1096/fj.08-121210 · Cited by 56
Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism
Petersen, P. S., Jin, C., Madsen, A. N., Rasmussen, M., Kuhre, R. E., Egerod, K. L., Nielsen, L. B., Schwartz, T. W., & Holst, B. (2011) · The FASEB Journal · doi:10.1096/fj.11-184531 · Cited by 56
Haitina, T., Fredriksson, R., Foord, S. M., Schiöth, H. B., & Gloriam, D. E. I. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-24 · Cited by 54
Adams, J. W., Wang, J., Davis, J. R., Liaw, C. W., Gaidarov, I., Gatlin, J., Dalton, N. D., Gu, Y., Ross, J., Behan, D. P., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00368.2008 · Cited by 51
Molecular Genetic Analysis of a Human Neuropeptide Y Receptor
Rose, P. M., Lynch, J. S., Frazier, S. T., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3622 · Cited by 49
Inactivation of the EGF‐TM7 receptor EMR4 after the Pan‐Homo divergence
Hamann, J., Kwakkenbos, M. J., de Jong, E. C., Heus, H. C., Olsen, A. S., & van Lier, R. A. W. (2003) · European Journal of Immunology · doi:10.1002/eji.200323881 · Cited by 48
Zhu, Y., & Murakami, F. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22041 · Cited by 47
Functional polymorphism in the GPR55 gene is associated with anorexia nervosa
Ishiguro, H., Onaivi, E. S., Horiuchi, Y., Imai, K., Komaki, G., Ishikawa, T., Suzuki, M., Watanabe, Y., Ando, T., Higuchi, S., et al. (2010) · Synapse · doi:10.1002/syn.20821 · Cited by 46
Hase, M., Yokomizo, T., Shimizu, T., & Nakamura, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709487200 · Cited by 43
The ligand specificity of the G-protein-coupled receptor GPR34
Ritscher, L., Engemaier, E., Stäubert, C., Liebscher, I., Schmidt, P., Hermsdorf, T., Römpler, H., Schulz, A., & Schöneberg, T. (2012) · Biochemical Journal · doi:10.1042/bj20112090 · Cited by 40
Scientific Priorities in North Korea
Robinson, C., Lee, M.-K., & Burnham, G. M. (2005) · Science · doi:10.1126/science.307.5707.206c · Cited by 38
International Union of Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors
Klos, A., Wende, E., Wareham, K., & Monk, P. N. (2013) · Cited by 38
Discovery of a null mutation in a human trace amine receptor gene
Vanti, W. B., Muglia, P., Nguyen, T., Cheng, R., Kennedy, J. L., George, S. R., & O’Dowd, B. F. (2003) · Genomics · doi:10.1016/s0888-7543(03)00173-3 · Cited by 37
GPR35 Is a Target of the Loop Diuretic Drugs Bumetanide and Furosemide
Yang, Y., Fu, A., Wu, X., & Reagan, J. D. (2012) · Pharmacology · doi:10.1159/000335127 · Cited by 35
The Rise and Fall of the Chemoattractant Receptor GPR33
Römpler, H., Schulz, A., Pitra, C., Coop, G., Przeworski, M., Pääbo, S., & Schöneberg, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503586200 · Cited by 32
Marazziti, D., Pietro, C. D., Mandillo, S., Golini, E., Matteoni, R., & Tocchini‐Valentini, G. P. (2011) · The FASEB Journal · doi:10.1096/fj.10-175737 · Cited by 32
Sequence Polymorphisms Provide a Common Consensus Sequence for GPR41 and GPR42
Liaw, C. W., & Connolly, D. T. (2009) · DNA and Cell Biology · doi:10.1089/dna.2009.0916 · Cited by 30
Malik, L., Kelly, N. M., Ma, J., Currier, E. A., Burstein, E. S., & Olsson, R. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.085 · Cited by 29
Label-Free Phenotypic Profiling Identified D-Luciferin as a GPR35 Agonist
Hu, H., Deng, H., & Ye, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034934 · Cited by 29
Orphan GPCRs and Methods for Identifying Their Ligands
Yoshida, M., Miyazato, M., & Kangawa, K. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381272-8.00002-7 · Cited by 20
Sensory Neuron-Specific Mas-Related Gene-X1 Receptors Resist Agonist-Promoted Endocytosis
Solinski, H. J., Boekhoff, I., Bouvier, M., Gudermann, T. W., & Breit, A. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.063867 · Cited by 20
Involvement of the chemokine-like receptor GPR33 in innate immunity
Bohnekamp, J., Böselt, I., Saalbach, A., Tönjes, A., Kovacs, P. L., Biebermann, H., Manvelyan, H. M., Polte, T., Gašperíková, D., Lkhagvasuren, S., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.077 · Cited by 19
Rowan, L. (2005) · Science · doi:10.1126/science.1110795 · Cited by 16
Novel Neuropeptides as Ligands of Orphan G Protein-Coupled Receptors
Zhang, Y., Wang, Z., Parks, G. S., & Civelli, O. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797416110 · Cited by 12
Cited by
GPCRdb: an information system for G protein-coupled receptors
Isberg, V., Mordalski, S., Munk, C., Rataj, K., Harpsøe, K., Hauser, A. S., Vroling, B., Bojarski, A. J., Vriend, G., & Gloriam, D. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1178 · Cited by 1,072
Free Fatty Acid Receptors in Health and Disease
Kimura, I., Ichimura, A., Ohue-Kitano, R., & Igarashi, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00041.2018 · Cited by 1,018
Pawson, A. J., Sharman, J. L., Benson, H. E., Faccenda, E., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., Southan, C., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1143 · Cited by 849
Self-citationDavenport, A. P., Hyndman, K. A., Dhaun, N., Southan, C., Kohan, D. E., Pollock, J. S., Pollock, D. M., Webb, D. J., & Maguire, J. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011833 · Cited by 772
Self-citationLPA receptor signaling: pharmacology, physiology, and pathophysiology
Yung, Y. C., Stoddard, N. C., & Chun, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046458 · Cited by 710
Metadata
- Authors
- Davenport, A. P., Alexander, S. P. H., Sharman, J. L., Pawson, A. J., Benson, H. E., Monaghan, A. E., Liew, W. C., Mpamhanga, C. P., Bonner, T. I., Neubig, R. R., Pin, J. P., Spedding, M., & Harmar, A. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 65
- Issue
- 3
- Pages
- 967-986
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2162185858
- Cited by
- 327
- References
- 230
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.